Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

October 26-28, 2017

New York, New York
Sheraton New York

Faculty

Ash A. Alizadeh, MD, PhD
Stanford Comprehensive Cancer Center
Stanford, California
United States

John N. Allan, MD
Weill Cornell Medicine
New York, New York
United States

Kenneth C. Anderson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
United States

Stephen M. Ansell, MD, PhD
Mayo Clinic
Rochester, Minnesota
United States

David E. Avigan, MD
Beth Israel Deaconess Medical Center
Boston, Massachusetts
United States

James R. Berenson, MD
Institute For Myeloma And Bone Cancer Research
West Hollywood, California
United States

Jennifer R. Brown, MD, PhD
Dana-Farber Cancer Insitute
Boston, Massachusetts
United States

Carla Casulo, MD
University of Rochester Medical Center
Rochester, New York
United States

Leandro Cerchietti, MD
Weill Cornell Medicine
New York, New York
United States

Ajai Chari, MD
Mount Sinai Hospital
New York, New York
United States

Robert W. Chen, MD
City of Hope Duarte
Duarte, California

Selina Chen-Kiang, PhD
Weill Cornell Medicine
New York, New York
United States

Nicholas Chiorazzi, MD
The Feinstein Institute of Medical Research
Manhasset, New York
United States

Hearn Jay Cho, MD, PhD
Mt. Sinai School of Medicine
Tisch Cancer Institute
New York, New York
United States

Adam D. Cohen, MD
Penn Medicine
Philadelphia, Pennsylvania
United States

Morton Coleman, MD
Weill Cornell Medicine
New York, New York
United States

Alexey V. Danilov, MD, PhD
Oregon Health & Science University
Portland, Oregon

Sven De Vos, MD, PhD
Ronald Regan UCLA Medical Center
Los Angeles, California

Catherine S.M. Diefenbach, MD
NYU Langone Health
New York, New York

Scott A. Ely, MD, MPH
Weill Cornell Medicine
New York, New York
United States

Andrew Evens, DO, MSc
Tufts Cancer Institute
Boston, Massachusetts
United States

Thierry Facon, MD
Lille University Hospital
Villeneuve-d'ascq, France

Ian Flinn, MD
Tennessee Oncology
Nashville, Tennessee
United States

Jonathan Friedberg, MD
University of Rochester
Rochester, New York
United States

Richard R. Furman, MD
Weill Cornell Medicine
New York, New York
United States

Michele Ghielmini, MD
Oncology Institute of Southern Switzerland
Bellinzona, Switzerland

Andre P. Goy, MD
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States

Jeremy Heinerich, PA-C
Weill Cornell Medicine
New York, New York
United States

Peter Hillmen, MB ChB, PhD
University of Leeds
Leeds, United Kingdom

Neil E. Kay, MD
Mayo Clinic
Rochester, Minnesota
United States

Guenther Koehne, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, New York
United States

Nadia Kralovic, PA-C
Memorial Sloan Kettering Cancer Center
New York, New York
United States

Ann S. Lacasce, MD, MMSc
Dana-Farber Cancer Institute
Boston, Massachusetts
United States

Dan Landau, MD, PhD
Weill Cornell Medicine
New York, New York
United States

C. Ola Landgren, MD, PhD
Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine
New York, New York
United States

Suzanne Lentzsch, MD, PhD
Columbia University Medical Center
New York, New York
United States

John P. Leonard, MD
Weill Cornell Medicine
New York, New York
United States

Brian K. Link, MD
University of Iowa Health Care
Iowa City, Iowa
United States

Sagar Lonial, MD
Winship Cancer Center, Emory School of Medicine
Atlanta, Georgia
United States

David G. Maloney, MD, PhD
Fred Hutchinson Cancer Research Center
University of Washington
Seattle, Washington
United States

Tomer M. Mark, MD, MSc
University of Colorado
Denver, Colorado
United States

Peter Martin, MD
Weill Cornell Medicine
New York, New York
United States

Anthony R. Mato, MD
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
United States

Ari M. Melnick, MD
Weill Cornell Medicine
New York, New York
United States

Joseph R. Mikhael, MD, MEd, FRCPC, FACP
Mayo Clinic Arizona
Phoenix, Arizona
United States

Philippe Moreau, MD
University Hospital of Nantes
Nantes, France

Gsaeth J. Morgan, MD, PhD, FRCP, FRCPath
University of Arkansas for Medical Sciences
Little Rock, Arkansas
United States

Ruben Niesvizky, MD
Weill Cornell Medicine
New York, New York
United States

Roger N. Pearse, MD, PhD
Weill Cornell Medicine
New York, New York

Arthur Perry, PA-C
Weill Cornell Medicine
New York, New York, United States

Oliver W. Press, MD, PhD
Fred Hutchinson Cancer Research Center
Seattle, Washington
United States

Barbara Pro, MD
Robert H. Lurie Comprehensive
Cancer Center of Northwestern University

Kanti Rai, MD
Hofstra Northwell School of Medicine
New Hyde Park, New York
United States

Noopur Raje, MD
Harvard Medical School
Boston, Massachusetts
United States

Kristy L. Richards, MD, PhD
Weill Cornell Medicine
New York, New York
United States

Paul G. Richardson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
United States

Cara Rosenbaum, MD
Weill Cornell Medicine
New York, New York
United States

Adriana C. Rossi, MD
Weill Cornell Medicine
New York, New York
United States

Jia Ruan, MD, PhD
Weill Cornell Medicine
New York, New York
United States

Sarah Rutherford, MD
Weill Cornell Medicine
New York, New York
United States

Jennifer Santamala, PharmD
NewYork-Presbyterian
New York, New York
United States

Maureen Thyne, RPA-C, CG(ASCP)
Weill Cornell Medicine
New York, New York
United States

Emilee Thomas, PA-C
Weill Cornell Medicine
New York, New York
United States

Steven Treon, MD, PhD
Dana-Farber Cancer Institute
Boston, Massachusetts
United States

Koen Van Besien, MD, PhD
Weill Cornell Medicine
New York, New York
United States

Andrew D. Zelenetz, MD
Memorial Sloan Kettering Cancer Center
New York, New York
United States